PRESS RELEASE published on 01/24/2024 at 14:00, 1 year 10 months ago AiCuris and the German Center for Infection Research (DZIF) sign Collaboration and License Option Agreement AiCuris and the German Center for Infection Research (DZIF) have signed a collaboration and license option agreement to discover new active agents for the treatment and prophylaxis of infections of immunocompromised patients. The partnership aims to develop novel therapies for patients with high medical need. The financial details of the collaboration were not disclosed. For more information, visit www.dzif.de and www.aicuris.com. AiCuris German Center For Infection Research Collaboration License Option Agreement Immunocompromised Patients
PRESS RELEASE published on 09/28/2023 at 14:00, 2 years 2 months ago AiCuris´ AiCubator Program Opens New Application Round for Innovative Projects with Focus on Treatment Options for Viral Infections in Immunocompromised Patients
PRESS RELEASE published on 08/23/2023 at 14:00, 2 years 3 months ago AiCuris Received 30 Million Euros Milestone Payment from Licensing Partner MSD Following U.S. FDA Approval of PREVYMIS® (letermovir) in Second Indication
PRESS RELEASE published on 07/06/2023 at 14:00, 2 years 5 months ago AiCuris Announces Strategic Shift to Focus Development and Commercialization of Anti-infectives for Immunocompromised Patients
PRESS RELEASE published on 04/04/2023 at 14:00, 2 years 8 months ago AiCuris AG Announces Appointment of Larry Edwards as Chief Executive Officer and Formation of U.S. Subsidiary
Published on 12/19/2025 at 03:15, 7 hours 22 minutes ago Tactical Resources Announces Receipt Of Final Order Approving Arrangement With Plum Acquisition Corp. III
Published on 12/19/2025 at 01:10, 9 hours 27 minutes ago Ostrom Climate Exits Existing UPRIIS ERPA Arrangements
Published on 12/19/2025 at 01:00, 9 hours 37 minutes ago Sun Peak Metals Announces Completion of Acquisition of Saudi Discovery Company SPV Limited
Published on 12/19/2025 at 00:50, 9 hours 47 minutes ago High Resolution Gravity Survey Targets Challenger Repeats
Published on 12/19/2025 at 00:00, 10 hours 37 minutes ago LIR Life Sciences Announces Appointment of Dr. Peter Singer as Scientific Advisor
Published on 12/19/2025 at 10:00, 37 minutes ago Partners Group to sell stake in Australian wind farm
Published on 12/19/2025 at 09:35, 1 hour 2 minutes ago Top sports physio says football bosses failing to properly protect players' health this Christmas as injuries expected to rise
Published on 12/19/2025 at 09:31, 1 hour 5 minutes ago Original-Research: THE NAGA GROUP AG (von NuWays AG): BUY
Published on 12/19/2025 at 09:26, 1 hour 10 minutes ago Original-Research: SYNBIOTIC SE (von NuWays AG): BUY
Published on 12/19/2025 at 09:21, 1 hour 15 minutes ago Original-Research: Netfonds AG (von NuWays AG): BUY
Published on 12/19/2025 at 08:30, 2 hours 7 minutes ago Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 2 hours 7 minutes ago Réduction du capital par voie d’annulation d’actions propres
Published on 12/19/2025 at 07:00, 3 hours 37 minutes ago EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Published on 12/19/2025 at 07:00, 3 hours 37 minutes ago EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION
Published on 12/18/2025 at 18:30, 16 hours 7 minutes ago Schneider Electric completes transaction to acquire remaining 35% stake in existing Indian JV
